ATR and neoplasm: Remarkably, the ATMi AZD0156, but not the ATRi AZD6738, robustly restored fork degradation in BRCA- H2AX-deficient cells (Fig. 4c), indicating that the ATR signalling branch is dispensable for fork protection in these tumours.